Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1953 1
1954 1
1955 1
1956 2
1957 4
1958 2
1959 1
1960 5
1961 12
1962 18
1963 18
1964 14
1965 11
1966 35
1967 29
1968 25
1969 32
1970 50
1971 40
1972 67
1973 54
1974 55
1975 25
1976 42
1977 39
1978 42
1979 48
1980 43
1981 50
1982 56
1983 73
1984 79
1985 72
1986 88
1987 82
1988 96
1989 104
1990 116
1991 111
1992 83
1993 94
1994 101
1995 115
1996 136
1997 146
1998 121
1999 149
2000 126
2001 131
2002 163
2003 172
2004 171
2005 197
2006 186
2007 214
2008 210
2009 196
2010 219
2011 221
2012 236
2013 218
2014 172
2015 210
2016 203
2017 218
2018 260
2019 252
2020 326
2021 352
2022 365
2023 363
2024 191

Text availability

Article attribute

Article type

Publication date

Search Results

7,539 results

Results by year

Filters applied: . Clear all
Page 1
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.
Huseni MA, Wang L, Klementowicz JE, Yuen K, Breart B, Orr C, Liu LF, Li Y, Gupta V, Li C, Rishipathak D, Peng J, Şenbabaoǧlu Y, Modrusan Z, Keerthivasan S, Madireddi S, Chen YJ, Fraser EJ, Leng N, Hamidi H, Koeppen H, Ziai J, Hashimoto K, Fassò M, Williams P, McDermott DF, Rosenberg JE, Powles T, Emens LA, Hegde PS, Mellman I, Turley SJ, Wilson MS, Mariathasan S, Molinero L, Merchant M, West NR. Huseni MA, et al. Among authors: hashimoto k. Cell Rep Med. 2023 Jan 17;4(1):100878. doi: 10.1016/j.xcrm.2022.100878. Epub 2023 Jan 3. Cell Rep Med. 2023. PMID: 36599350 Free PMC article.
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial.
Okuma Y, Kubota K, Shimokawa M, Hashimoto K, Kawashima Y, Sakamoto T, Wakui H, Murakami S, Okishio K, Hayashihara K, Ohe Y; Tokyo Cooperative Oncology Group (TCOG). Okuma Y, et al. Among authors: hashimoto k. JAMA Oncol. 2024 Jan 1;10(1):43-51. doi: 10.1001/jamaoncol.2023.5013. JAMA Oncol. 2024. PMID: 37991747
New treatment strategies for mental health.
Hashimoto K, Schmitt A. Hashimoto K, et al. Eur Arch Psychiatry Clin Neurosci. 2023 Oct;273(7):1399-1401. doi: 10.1007/s00406-023-01682-y. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 37603079 No abstract available.
Arketamine for cognitive impairment in psychiatric disorders.
Hashimoto K. Hashimoto K. Eur Arch Psychiatry Clin Neurosci. 2023 Oct;273(7):1513-1525. doi: 10.1007/s00406-023-01570-5. Epub 2023 Feb 14. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 36786865 Free PMC article. Review.
7,539 results